TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Donanemab treatment effect by baseline tau burden and disease severity: Observations from the TRAILBLAZER-ALZ 2 trial.

Lars L Raket et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.